source
- Celcuity's Revtorpyk receives FDA approval, but launch delay pushes stock lowerThe FDA announced approval of Celcuity’s oncology candidate Revtorpyk on Tuesday, marking the company’s first cancer drug clearance. Analysts had broadly expected the approval and had priced the s…
- GSK to launch large trial testing shingles vaccine’s potential to reduce Alzheimer’s riskGSK announced it will conduct a large-scale clinical study to evaluate whether the shingles vaccine can lower the risk of developing Alzheimer’s disease. The move follows observations from analyses…